Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4
Adult
Aged
Animals
Antigens, Viral
/ immunology
Asymptomatic Infections
CD4-Positive T-Lymphocytes
/ immunology
CD8-Positive T-Lymphocytes
/ virology
Computer Simulation
Epitopes, T-Lymphocyte
/ immunology
Female
HLA-DR Antigens
/ genetics
Haplotypes
Humans
Immunodominant Epitopes
/ immunology
Immunologic Memory
Interferon-gamma
/ immunology
Keratitis, Herpetic
/ immunology
Lysosomal-Associated Membrane Protein 1
/ immunology
Male
Mice
Mice, Transgenic
Middle Aged
Phenotype
Viral Proteins
/ immunology
Young Adult
CD4+ T cells
HLA transgenic mice
HSV-1
UL46
VP11/12
epitope
human
mapping
tegument protein
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
17 03 2020
17 03 2020
Historique:
received:
25
11
2019
accepted:
02
01
2020
pubmed:
10
1
2020
medline:
15
9
2020
entrez:
10
1
2020
Statut:
epublish
Résumé
While the role of CD8
Identifiants
pubmed: 31915285
pii: JVI.01991-19
doi: 10.1128/JVI.01991-19
pmc: PMC7081904
pii:
doi:
Substances chimiques
Antigens, Viral
0
Epitopes, T-Lymphocyte
0
HLA-DR Antigens
0
Immunodominant Epitopes
0
Lysosomal-Associated Membrane Protein 1
0
UL46 protein, Human herpesvirus 1
0
Viral Proteins
0
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R41 AI138764
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026103
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI143348
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY019896
Pays : United States
Organisme : NIAID NIH HHS
ID : R43 AI124911
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI143326
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY024618
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI110902
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI147499
Pays : United States
Informations de copyright
Copyright © 2020 American Society for Microbiology.
Références
N Engl J Med. 1998 Jul 30;339(5):300-6
pubmed: 9696640
J Immunol. 2013 Nov 15;191(10):5124-38
pubmed: 24101547
J Virol. 2012 Apr;86(8):4328-39
pubmed: 22318154
J Virol. 2019 Apr 17;93(9):
pubmed: 30787156
Front Oncol. 2019 Feb 14;9:52
pubmed: 30838171
Vaccine. 2019 Jan 3;37(1):61-68
pubmed: 30471955
Eur J Immunol. 1999 Nov;29(11):3674-82
pubmed: 10556823
J Virol. 2019 Aug 28;93(18):
pubmed: 31217250
Nat Immunol. 2009 May;10(5):524-30
pubmed: 19305395
Infect Immun. 2010 Oct;78(10):4356-62
pubmed: 20660611
Nature. 2018 Jun;558(7710):454-459
pubmed: 29899446
J Infect Dis. 2000 Sep;182(3):923-7
pubmed: 10950790
J Virol. 2012 Apr;86(8):4358-69
pubmed: 22318137
J Immunol. 1999 Apr 1;162(7):4079-87
pubmed: 10201931
Clin Dev Immunol. 2012;2012:187585
pubmed: 22548113
J Infect Dis. 2018 Nov 5;218(12):1890-1899
pubmed: 29982727
Curr Protoc Immunol. 2013 Feb;Chapter 18:Unit 18.3.
pubmed: 23392640
J Gen Virol. 1998 Feb;79 ( Pt 2):353-61
pubmed: 9472620
J Immunol. 2008 Jul 1;181(1):431-9
pubmed: 18566409
Ocul Surf. 2006 Oct;4(4):178-87
pubmed: 17146573
PLoS One. 2015 Oct 28;10(10):e0140765
pubmed: 26510007
Herpes. 2004 Aug;11 Suppl 3:161A-169A
pubmed: 15319086
Virology. 2008 Jul 5;376(2):279-89
pubmed: 18452963
J Virol. 2009 May;83(10):5256-68
pubmed: 19279095
J Infect Dis. 2017 Mar 15;215(6):856-864
pubmed: 28329211
Immunol Today. 1994 Jan;15(1):41-2
pubmed: 8136013
J Neurovirol. 2015 Oct;21(5):508-17
pubmed: 26002839
Nat Commun. 2016 May 10;7:11514
pubmed: 27160938
Hum Immunol. 2000 Aug;61(8):764-79
pubmed: 10980387
J Virol. 2006 Jun;80(11):5509-15
pubmed: 16699031
Vaccine. 2014 Nov 28;32(50):6733-45
pubmed: 25446827
J Virol. 2016 Mar 28;90(8):3913-3928
pubmed: 26842468
Trends Immunol. 2001 Nov;22(11):583-8
pubmed: 11698198
J Immunol. 2008 Nov 1;181(9):6604-15
pubmed: 18941251
J Virol. 2005 Dec;79(24):15289-301
pubmed: 16306600
Virology. 2014 Sep;464-465:296-311
pubmed: 25108380
J Immunol. 2019 Jan 15;202(2):514-526
pubmed: 30530484
J Immunol. 2003 Apr 15;170(8):4380-8
pubmed: 12682275
J Immunol. 2000 Mar 15;164(6):3177-84
pubmed: 10706708
Immunol Rev. 2010 May;235(1):244-66
pubmed: 20536568
J Virol. 2015 Jul;89(13):6619-32
pubmed: 25878105
Cell. 2012 Dec 21;151(7):1557-68
pubmed: 23260142
J Virol. 2019 Jun 14;93(13):
pubmed: 30971470
Cancer Immunol Immunother. 2009 Feb;58(2):187-200
pubmed: 18584174
J Immunol. 2012 Nov 1;189(9):4496-509
pubmed: 23018456
N Engl J Med. 2012 Jan 5;366(1):34-43
pubmed: 22216840
Curr Trends Immunol. 2012;13:51-68
pubmed: 23355766
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):4013-28
pubmed: 26098469
Hum Immunol. 2014 Aug;75(8):715-29
pubmed: 24798939
Vaccine. 2019 Jan 21;37(4):664-669
pubmed: 30551986
Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2607-12
pubmed: 10937573
Curr Eye Res. 2016 Jun;41(6):747-56
pubmed: 26398722
J Immunol. 2013 Sep 1;191(5):2258-65
pubmed: 23878317
J Virol. 1995 Dec;69(12):8178-9
pubmed: 7494346
Nat Immunol. 2013 Dec;14(12):1294-301
pubmed: 24162776
J Virol. 2008 Oct;82(19):9678-88
pubmed: 18667492
Eur J Immunol. 2019 Jun;49(6):849-852
pubmed: 31017296
Proc Natl Acad Sci U S A. 1988 Nov;85(21):8191-5
pubmed: 2973061
Methods Mol Med. 2001;66:349-60
pubmed: 21336767
J Immunol. 2013 Jun 1;190(11):5757-63
pubmed: 23636059
N Engl J Med. 2002 Nov 21;347(21):1652-61
pubmed: 12444179
J Immunol. 2011 Apr 1;186(7):3927-33
pubmed: 21357536
J Virol. 2017 Jan 3;91(2):
pubmed: 27847359
J Immunol. 2008 Jan 1;180(1):426-37
pubmed: 18097044
J Virol. 2003 Sep;77(17):9463-73
pubmed: 12915561
J Virol. 2006 Sep;80(17):8351-61
pubmed: 16912286
Prog Med Virol. 1987;34:89-128
pubmed: 2821579
Nucleic Acids Res. 2015 Jul 1;43(W1):W431-5
pubmed: 25969449
Bioinformatics. 2007 Jan 15;23(2):e148-55
pubmed: 17237084
J Virol. 2019 Feb 5;93(4):
pubmed: 30487281
J Immunol. 2017 Jul 1;199(1):186-203
pubmed: 28539429
Mol Immunol. 2013 Apr;53(4):453-9
pubmed: 23147561